The Brd-Inhibitor OTX015 Shows Pre-Clinical Activity in Anaplastic Large T-Cell Lymphoma (ALCL)
Michela Boi(Cornell University), Francesco Bertoni(Ente Ospedaliero Cantonale), Paola Bonetti(Center for Pediatric Endocrinology Zurich), Anastasios Stathis(Princess Margaret Cancer Centre), Esteban Cvitkovic(Inserm), Emanuele Zucca(Università della Svizzera italiana), Giorgio Inghirami(Cornell University), Maria Grazia Tibiletti(University of Insubria), Maurilio Ponzoni(San Raffaele University of Rome)
Cited by 8
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
Advanced pancreatic carcinoma: current treatment and future challenges
|Nature Reviews Clinical Oncology|2010|791